Skip to main content
. 2023 Mar 9;8(2):101183. doi: 10.1016/j.esmoop.2023.101183

Table 2.

Adverse events

Adverse event,n(%) Grade 1 Grade 2 Grade 3 Grade 4
Abdominal pain 1 (6) 4 (24) 0 0
Anorexia 2 (12) 5 (29) 0 0
Bronchial infection 0 3 (18) 0 0
Bruising 2 (12) 0 0 0
Constipation 2 (12) 1 (6) 0 0
Cough 2 (12) 0 1 (6) 0
Creatinine increase 1 (6) 1 (6) 0 0
Depression 0 2 (12) 0 0
Diarrhea 8 (47) 4 (24) 1(6) 0
Dizziness 1 (6) 1 (6) 0 0
Dry mouth 3 (18) 1 (6) 0 0
Dry skin 3 (18) 1 (6) 0 0
Dysgeusia 2 (12) 0 0 0
Dyspepsia 1 (6) 1 (6) 0 0
Dyspnea 1 (6) 5 (29) 0 0
Edema (limbs) 2 (12) 0 0 0
Epistaxis 2 (12) 0 0 0
Fall 1 (6) 2 (12) 0 0
Fatigue 5 (29) 4 (23) 0 0
Flank pain 2 (12) 0 0 0
Post-nasal drip 2 (12) 0 0 0
Productive cough 2 (12) 1 (6) 1 (6) 0
QT interval prolonged 0 0 2 (12) 0
Rash acneiform 4 (23) 0 0 0
Rash maculopapular 4 (23) 0 0 0
Thromboembolic event 0 0 2 (12) 1 (6)
Tumor pain 1 (6) 1 (6) 0 0
Urinary tract infection 0 2 (12) 0 0
Vomiting 2 (12) 3 (18) 0 0
Weight loss 5 (29) 1 (6) 1 (6) 0